Pathophysiology and management of anemia in chronic progressive renal failure.

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Hypoproliferative anemia is a predictable and serious complication of progressive renal failure and contributes significantly to the overall morbidity of the uremic state. Until recently, there has been no satisfactory therapy to resolve the anemia. Now the anemia can be explicitly corrected with erythropoietin-replacement therapy, and the clinical debility generally attributable to renal insufficiency can be lessened and retarded. Anemia must no longer be regarded as an intractable consequence of the uremic syndrome and should be managed as conscientiously as the other polysystemic features of uremia.

Original languageEnglish (US)
Pages (from-to)175-182
Number of pages8
JournalSeminars in veterinary medicine and surgery (small animal)
Issue number3
StatePublished - Aug 1992

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Pathophysiology and management of anemia in chronic progressive renal failure.'. Together they form a unique fingerprint.

Cite this